These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 51833)

  • 1. Non-organ-specific and tumour-specific antibodies in children with Wilms' tumour.
    Kumar S; Taylor G
    Int J Cancer; 1975 Sep; 16(3):448-55. PubMed ID: 51833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-specific antibodies reactive with cell-surface antigens in children with Wilms' tumour.
    Kumar S; Waghe M; Taylor G
    Int J Cancer; 1977 Mar; 19(3):351-5. PubMed ID: 191407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
    Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
    Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
    Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of class I and II major histocompatibility complex antigens in Wilms' tumour and normal developing human kidney.
    Borthwick GM; Hughes L; Holmes CH; Davis SJ; Stirrat GM
    Br J Cancer; 1988 Dec; 58(6):753-61. PubMed ID: 2465017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
    Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
    Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal antibody recognizing the blastemal element of Wilms' tumors and fetal kidneys.
    Tarnowski BI; Hazen-Martin DJ; Garvin AJ; Sens MA; Sens DA
    Pediatr Pathol; 1994; 14(5):849-62. PubMed ID: 7808983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
    Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
    Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
    Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aniridia-Wilms' tumour syndrome--a case report.
    Vidyasagar MS; Sagar SV; Kumar GR; Rao P
    Indian J Ophthalmol; 1992; 40(4):122-3. PubMed ID: 1338631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anaplastic type of Wilms' tumour].
    Vujanić GM; Aleksandrović S
    Srp Arh Celok Lek; 1990; 118(9-10):353-6. PubMed ID: 1966350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour.
    Rebhandl W; Rami B; Turnbull J; Felberbauer FX; Paya K; Bancher-Todesca D; Gherardini R; Mittlboeck M; Horcher E
    Br J Cancer; 1998 Dec; 78(11):1503-6. PubMed ID: 9836484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.
    Begent J; Sebire NJ; Levitt G; Brock P; Jones KP; Ell P; Gordon I; Anderson J
    Eur J Cancer; 2011 Feb; 47(3):389-96. PubMed ID: 21074411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of childhood renal tumours using xenogeneic antiserum.
    Kumar S; Marsden HB; Kumar P
    Br J Urol; 1980 Aug; 52(4):245-52. PubMed ID: 6252999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.
    Tretiakova M; Turkyilmaz M; Grushko T; Kocherginsky M; Rubin C; Teh B; Yang XJ
    J Clin Pathol; 2006 Dec; 59(12):1272-7. PubMed ID: 16556665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.
    Jose DG; Seshadri R
    Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular and cellular biology of Wilms' tumour.
    Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
    Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of cardiac septal defects in children with Wilms' tumour and other malignant diseases.
    Stiller CA; Lennox EL; Wilson LM
    Carcinogenesis; 1987 Jan; 8(1):129-32. PubMed ID: 3026677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.